- Bristol-Myers Squibb Co.
- SmithKline Beecham
- Novartis AG
- Discovery Partners International Inc.
- ArQule Inc.
- Accelrys Inc.
- Pfizer Inc.
- Monsanto Co.
- GD Searle & Co.
- Lexicon Pharmaceuticals Inc.
- Incyte Corp.
- Human Genome Sciences Inc.
- Glaxo Wellcome PLC
- Merck KGaA
- Affymetrix Inc.
- Morphochem Inc.
- Hexagen PLC
- DuPont Pharmaceuticals Co.
- Array BioPharma Inc.
- Vertex Pharmaceuticals LLC
- Merck & Co. Inc.
- Irori develops drug discovery system for Rhone-Poulenc Rorer
- Hewlett-Packard joins Caliper in LabChip development
- SmithKline in $125 million deal with Human Genome Sciences
- Immusol designs ribozymes for Pfizer targets
- Bristol-Myers swaps with Lipha for US Glucophage rights
- BMS & Pharmacopeia sign $40mm immunology/inflammation deal
- Roche to evaluate Affymetrix's GeneChip technology
- Incyte and NetGenics develop software product
- Lexicon, DuPont Pharmaceuticals swap genomics technologies
- SmithKline and Evotec to collaborate on EVOscreen
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. firstname.lastname@example.org.
All fields are required.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.